Cargando…
MicroRNA-631 Resensitizes Doxorubicin-Resistant Chondrosarcoma Cells by Targeting Apelin
Chondrosarcoma is the second most common type of bone cancer. Surgical resection is the best choice for clinical treatment. High-grade chondrosarcoma is destructive and is more possible to metastasis, which is difficult to remove using surgery. Doxorubicin (Dox) is the most commonly used chemotherap...
Autores principales: | Chen, Jui-Chieh, Shih, Hsun-Chang, Lin, Chih-Yang, Guo, Jeng-Hung, Huang, Cheng, Huang, Hsiu-Chen, Chong, Zhi-Yong, Tang, Chih-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820978/ https://www.ncbi.nlm.nih.gov/pubmed/36614283 http://dx.doi.org/10.3390/ijms24010839 |
Ejemplares similares
-
Novel Strategies for the Treatment of Chondrosarcomas: Targeting Integrins
por: Chen, Jui-Chieh, et al.
Publicado: (2013) -
Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation
por: Lai, Hong-Yue, et al.
Publicado: (2021) -
Visfatin Promotes the Metastatic Potential of Chondrosarcoma Cells by Stimulating AP-1-Dependent MMP-2 Production in the MAPK Pathway
por: Hung, Shih-Ya, et al.
Publicado: (2021) -
The ACE2/Apelin Signaling, MicroRNAs, and Hypertension
por: Chen, Lai-Jiang, et al.
Publicado: (2015) -
Primary intradural extramedullary spinal mesenchymal chondrosarcoma: case report and literature review
por: Chen, Chih-Wei, et al.
Publicado: (2019)